Mayo in it for the long haul with Google

The Mayo Clinic has selected Google Cloud to anchor its digital development over the next 10 years.

The strategic partnership will allow the Minnesota-based institution to spend a full decade diving deeply into advanced cloud computing, data analytics, machine learning and AI, according to an announcement.

Under the agreement, Google Cloud will store Mayo Clinic data while its personnel support Mayo’s stepped-up drive to deploy select technologies within its clinical and business operations.

The partnership will allow the 129-year-old provider organization to “transform the way it advances virtual care with AI-enabled digital diagnostics,” Mayo said, adding that it will also lean on Google for help modernizing its medical research operations.  

Mayo Clinic will manage access to all data, according to the announcement.

Google CEO Sundar Pichai commented that healthcare is “one of the most important fields that technology will help transform over the next decade, and it’s a major area of investment for Google.”

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.